UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021013
Receipt No. R000024196
Scientific Title Phenotype classification of COPD
Date of disclosure of the study information 2016/04/01
Last modified on 2020/02/17 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Phenotype classification of COPD
Acronym COPD Phenotype
Scientific Title Phenotype classification of COPD
Scientific Title:Acronym COPD Phenotype
Region
Japan

Condition
Condition COPD
Classification by specialty
Pneumology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Phenotype analysis of COPD.
Basic objectives2 Others
Basic objectives -Others Phenotype classification of chronic obstructive pulmonary disease by clinical findings, laboratory findings, imaging findings, and to search for a biomarker.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes classify
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria A.Patients with COPD at Tokyo Medical and Dental University Hospital. (n=30)
B.Patients with COPD at Okinawa Prefectural Chubu Hospital. (n=30)
C. Patients without COPD at Tokyo Medical and Dental University Hospital or Okinawa Prefectural Chubu Hospital.(n=30)
Key exclusion criteria (1) Patients with severe liver, kidney disease, heart disease, hematologic disease, or severe complications.
(2) Patients whom doctors determined to be inappropriate as a subject.
Target sample size 90

Research contact person
Name of lead principal investigator
1st name Sumi
Middle name
Last name Yuki
Organization Tokyo Medical and Dental University
Division name School of health sciences, Faculty of Medicine. Biofunctional Informatics, Biomedical Laboratory Science
Zip code 113-8519
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
TEL 03-3813-6111
Email ysumi.pulm@tmd.ac.jp

Public contact
Name of contact person
1st name Yuki
Middle name
Last name Sumi
Organization Tokyo Medical and Dental University
Division name School of health sciences, Faculty of Medicine. Biofunctional Informatics, Biomedical Laboratory Sci
Zip code 113-8519
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
TEL 03-3813-6111
Homepage URL
Email ysumi.pulm@tmd.ac.jp

Sponsor
Institute Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization Tokyo Medical and Dental University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tokyo Medical and Dental University
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan
Tel 03-3813-6111
Email info.bec@tmd.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京医科歯科大学医学部附属病院(東京都)、沖縄県立中部病院(沖縄県)
Tokyo Medical and Dental University Hospital, Okinawa Prefectural Chubu Hospital.

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 02 Month 14 Day
Date of IRB
2016 Year 03 Month 22 Day
Anticipated trial start date
2016 Year 04 Month 01 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Patient profile, physical examination, Chest CT imaging, blood sampling results, collected lung function tests, the serum are collected.

Management information
Registered date
2016 Year 02 Month 14 Day
Last modified on
2020 Year 02 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024196